Molecular Characterization of Nonhemolytic and Nonpigmented Group B Streptococci Responsible for Human Invasive Infections

J Clin Microbiol. 2016 Jan;54(1):75-82. doi: 10.1128/JCM.02177-15. Epub 2015 Oct 21.

Abstract

Group B Streptococcus (GBS) is a common commensal bacterium in adults, but is also the leading cause of invasive bacterial infections in neonates in developed countries. The β-hemolysin/cytolysin (β-h/c), which is always associated with the production of an orange-to-red pigment, is a major virulence factor that is also used for GBS diagnosis. A collection of 1,776 independent clinical GBS strains isolated in France between 2006 and 2013 was evaluated on specific medium for β-h/c activity and pigment production. The genomic sequences of nonhemolytic and nonpigmented (NH/NP) strains were analyzed to identify the molecular basis of this phenotype. Gene deletions or complementations were carried out to confirm the genotype-phenotype association. Sixty-three GBS strains (3.5%) were NH/NP, and 47 of these (74.6%) originated from invasive infections, including bacteremia and meningitis, in neonates or adults. The mutations are localized predominantly in the cyl operon, encoding the β-h/c pigment biosynthetic pathway and, in the abx1 gene, encoding a CovSR regulator partner. In conclusion, although usually associated with GBS virulence, β-h/c pigment production is not absolutely required to cause human invasive infections. Caution should therefore be taken in the use of hemolysis and pigmentation as criteria for GBS diagnosis in routine clinical laboratory settings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bacteriological Techniques
  • Culture Media / chemistry
  • France / epidemiology
  • Gene Deletion
  • Genetic Association Studies
  • Genetic Complementation Test
  • Genome, Bacterial
  • Hemolysin Proteins / analysis*
  • Humans
  • Infant, Newborn
  • Pigments, Biological / analysis*
  • Sequence Analysis, DNA
  • Streptococcal Infections / epidemiology
  • Streptococcal Infections / microbiology*
  • Streptococcus agalactiae / classification
  • Streptococcus agalactiae / genetics*
  • Streptococcus agalactiae / isolation & purification*

Substances

  • Culture Media
  • Hemolysin Proteins
  • Pigments, Biological

Grants and funding

This work was supported by the Fondation pour la Recherche Médicale (grants DEQ20100318279 and DEQ20130326538), Laboratoire d'Excellence (LABEX) Integrative Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID), INSERM, CNRS, Université Paris Descartes, the Institut Pasteur, and Institut de Veille Sanitaire. A. Six was a recipient of a doctoral fellowship from the Ministère de la Recherche et de l'Enseignement Supérieur University Paris Descartes (contract 641 113 10). A. Firon was a recipient of a postdoctoral fellowship from the Fondation pour la Recherche Médicale (grant DEQ20130326538).